CALGARY,
AB, May 13, 2022 /CNW/ - Universal Ibogaine
Inc. (TSXV: IBO) (OTCQB: IBOGF) (FSE: JC4) ("UI" or the
"Company") a life sciences company with a mission to
transform addiction treatment through the use of medicalized
ibogaine and a global licensing model is pleased to announce that
UI Co-Founder Dr Alberto Sola will
present at the May 27 to 29 event:
From Research to Reality: Global Summit on Psychedelic Assisted
Therapies and Medicine which will be held in Toronto, Canada from May 27 to 29, 2022.
The Research to Reality event is presented by the Mental Health
Commission of Canada, the Center
for Addiction and Mental Health ("CAMH") and the Canadian Center on
Substance Abuse and Addiction.
The event will be attended by researchers, clinicians' policy
makers including representatives from Health Canada the FDA and the
Mexico Ministry of Health ("COFEPRIS").
Dr. Sola, is a co-founder of Universal Ibogaine and a member of
the Board of Directors, and he is the founder of the Clear Sky
Recovery ibogaine clinic operating in Cancun, Mexico. Alberto is a global
leader in ibogaine detox treatments. He will present his latest
findings in a panel titled "Ibogaine Hydrochloride and Acute
Opioid Detox., which will take place on Saturday May 28 at 4:15 PM
EST"
UI CEO Nick Karos noted:
"The importance of this event cannot be overstated. This is
the first event of its kind to bring together academic researchers,
real world technicians and government policy makers. We believe
this event will be an important catalyst for the industry and a
significant milestone for our company. This event will create
awareness at the highest levels of the incredible potential of
ibogaine."
About Universal Ibogaine
Inc.
UI is a life sciences company, with a mission to transform
addiction treatment through the use of medicalized ibogaine and a
global licensing model through a planned Canadian Clinical
Trial (focused on opioid use disorder), and ultimately to utilize
that protocol around the globe through planned future licensing
agreements. UI is concurrently developing a state of the art
holistic addiction treatment protocol at its Kelburn Recovery
Centre that, when paired with the planned ibogaine detox protocol,
is intended to revolutionize the way we treat addiction and
drastically improve the lives of individuals and families affected
by addiction.
NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES
PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX
VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR
ACCURACY OF THIS RELEASE.
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING
STATEMENTS
This news release may contain forward-looking statements and
information. Forward-looking information is frequently
characterized by words such as "plans", "expect", "project",
"intend", "will", "believe", "anticipate", "estimate", "scheduled",
"potential", or other similar words, or statements that certain
events or conditions "may", "should" or "could" occur. The
forward-looking statements and information are based on certain key
expectations and assumptions made by UI. Although UI
believes that the expectations and assumptions on which the
forward-looking statements are based are reasonable, undue
reliance should not be placed on the forward-looking statements
because UI can give no assurance that they will prove to be
correct.
Since forward-looking statements address future events and
conditions, by their very nature they involve inherent risks and
uncertainties. Actual results could differ materially from those
currently anticipated due to a number of factors and risks, which
include, but are not limited to, risks that required regulatory
approvals are not obtained. The reader is cautioned that
assumptions used in the preparation of such information, although
considered reasonable by UI at the time of preparation, may prove
to be incorrect and readers are cautioned not to place undue
reliance on forward-looking information, which speaks only to
conditions as of the date hereof. UI does not undertake any
obligation to release publicly any revisions to forward-looking
information contained herein to reflect events or circumstances
that occur after the date hereof or to reflect the occurrence of
unanticipated events, except as may be required under applicable
securities laws.
Related Links
https://universalibogaine.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/universal-ibogaine-co-founder-dr-alberto-sola-to-present-at-upcoming-research-to-reality-conference-301547153.html
SOURCE Universal Ibogaine Inc.
